GSK-3 inhibitor 4

Modify Date: 2024-01-26 14:36:05

GSK-3 inhibitor 4 Structure
GSK-3 inhibitor 4 structure
Common Name GSK-3 inhibitor 4
CAS Number 2227279-83-4 Molecular Weight 403.38
Density N/A Boiling Point N/A
Molecular Formula C22H15F2N5O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of GSK-3 inhibitor 4


GSK-3 inhibitor 4 is an orally active and brain-penetrant inhibitor of GSK-3, CDK2, and CDK5, with IC50 values of 0.56 nM (GSK-3β), 0.45 nM (GSK-3α), 0.47 μM, and 0.68 μM, respectively. GSK-3 inhibitor 4 effectively reduces the phosphorylation level of Tau protein. GSK-3 inhibitor 4 can be used in Alzheimer's disease (AD) studies[1].

 Names

Name GSK-3 inhibitor 4

 GSK-3 inhibitor 4 Biological Activity

Description GSK-3 inhibitor 4 is an orally active and brain-penetrant inhibitor of GSK-3, CDK2, and CDK5, with IC50 values of 0.56 nM (GSK-3β), 0.45 nM (GSK-3α), 0.47 μM, and 0.68 μM, respectively. GSK-3 inhibitor 4 effectively reduces the phosphorylation level of Tau protein. GSK-3 inhibitor 4 can be used in Alzheimer's disease (AD) studies[1].
Related Catalog
Target

GSK-3α:0.45 nM (IC50)

GSK-3β:0.56 nM (IC50)

CDK2:0.47 μM (IC50)

CDK5:0.68 μM (IC50)

References

[1]. Hartz RA, et al. Discovery of 2-(Anilino)pyrimidine-4-carboxamides as Highly Potent, Selective, and Orally Active Glycogen Synthase Kinase-3 (GSK-3) Inhibitors. J Med Chem. 2023 Jun 8;66(11):7534-7552.  

 Chemical & Physical Properties

Molecular Formula C22H15F2N5O
Molecular Weight 403.38